|Day Low/High||2.41 / 2.50|
|52 Wk Low/High||1.92 / 5.50|
We'll purchase more shares of Pixelworks and Inovio ahead of their quarterly results next week.
We made several trades and price target changes during a mixed week for the portfolio.
Sometimes, changing the price target is better than selling (or buying).
The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.
Identifying this week's bullish and bearish reversal patterns.
Investors in Inovio Pharmaceuticals Inc. saw new options begin trading today, for the September 15th expiration.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Sarepta Therapeutics, Inovio Pharmaceuticals and Mylan were among the biotech movers in premarket trading on July 20.
Vertex Pharmaceuticals, FibroGen and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading trading on July 19.
We brought a new name into the portfolio last week as the Fed's comments helped lift the market.
We made no trades during the holiday-shortened week, but added to our natural hedge today.
Exelixis, Omeros and Inovio Pharmaceuticals were among the biotech movers in premarket trading on July 10.
Inovio dMAb® product induces complete protection against lethal challenge with influenza A & B viruses in published preclinical study
We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.
We exited 2 positions and took some profits during a busy week for the portfolio.
We initiated a new position and made several other trades during a week of twists and turns.
We initiated 2 new positions in a week dominated by political events.
We're buying a small position in Inovio Pharmaceuticals and downgrading AcelRx.
Jim Cramer takes a closer look at Inovio Pharmaceuticals, a small biotech developing DNA-based immunotherapies to treat cancer.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.